Forest Laboratories Inc. (FRX): Today's Featured Health Care Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Forest Laboratories ( FRX) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 0.5%. By the end of trading, Forest Laboratories rose $1.30 (1.3%) to $99.55 on average volume. Throughout the day, 3,478,239 shares of Forest Laboratories exchanged hands as compared to its average daily volume of 3,215,000 shares. The stock ranged in a price between $98.13-$99.67 after having opened the day at $98.42 as compared to the previous trading day's close of $98.25. Other companies within the Health Care sector that increased today were: InterMune ( ITMN), up 170.8%, DARA Biosciences ( DARA), up 23.1%, Genocea Biosciences ( GNCA), up 21.1% and Sunesis Pharmaceuticals ( SNSS), up 17.5%.

Forest Laboratories, Inc. develops, manufactures, and sells branded forms of ethical drug products in the United States and Europe. Forest Laboratories has a market cap of $26.3 billion and is part of the drugs industry. Shares are up 63.7% year to date as of the close of trading on Monday. Currently there are 10 analysts that rate Forest Laboratories a buy, no analysts rate it a sell, and 13 rate it a hold.

TheStreet Ratings rates Forest Laboratories as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, compelling growth in net income, good cash flow from operations and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

On the negative front, Aoxing Pharmaceutical Company ( AXN), down 16.0%, Vivus ( VVUS), down 13.2%, Tenet Healthcare ( THC), down 9.1% and Star Scientific ( STSI), down 8.8% , were all laggards within the health care sector with WellPoint ( WLP) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Cramer: There Are Some Bargains Out There

Cramer: There Are Some Bargains Out There

Teva, Actavis, Other Generic Drugmakers May Be on Acquisition Trail

Teva, Actavis, Other Generic Drugmakers May Be on Acquisition Trail

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

Why Endo International Can Deliver Solid Rewards With Minimal Risk

Why Endo International Can Deliver Solid Rewards With Minimal Risk

3 Stocks Driving The Health Care Sector Higher

3 Stocks Driving The Health Care Sector Higher